ACC '04 Online Home

Annual Scientific Session Home
Daily Conference Highlights
Live Programs
On Demand Programs
Media/News
Educational Products
ACC '04 Session Recordings
Disclosures
CME Information
Technical Support
International Versions
Visit Cardiosource


Back
Originally Broadcast:
Tuesday, June 30, 2004
3:00 PM Eastern

This moderated discussion begins with a brief slide review of the topic by the presenter, which is followed by a question and answer session.


Marco A. Costa, MD, PhD  
Dr. Marco A. Costa, MD, PhD
Read Dr. Costa's Online Summary
Listen to the archived on-line audio discussion
Click on the Media Player of your choice to listen to the program: Need a plug-in?
Listen Now!
Click to Listen
Listen Now!
Click to Listen
Print Slides
Requires Adobe Reader
Similar Outcomes Between Patients with Native Coronary and Bypass Graft Disease Treated with Sirolimus-Eluting Stents in the SECURE Trial
As part of the compassionate-use SECURE trial, the long-term results using sirolimus-eluting stents were compared in patients with native coronary disease vs. those with bypass graft disease.

Presenter:
Marco A. Costa, MD, PhD
Assistant Professor of Medicine
Division of Cardiology
Director of Research and Cardiovascular Imaging Core Laboratories
University of Florida, Shands
Jacksonville, FL


Moderator:
Jamie B. Conti, MD, FACC
Associate Professor of Medicine
Co-Chair, 2004 Annual Scientific Session Program Committee
University of Florida
Gainesville, FL

Supported by an educational grant from:



  
© 2004 Cardiology Center Switzerland